mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |